title: Propofol infusion in children: when does an anesthetic tool become an intensive care liability?
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Wolf
authors.forename: Frank
authors.initials: F
authors.lastname: Potter
mesh_terms: D000108:Acetylcarnitine / Q000097:blood; D000328:Adult; D015415:Biomarkers / Q000097:blood; D002648:Child; D016292:Procedural Sedation / Q000009:adverse effects; D003422:Critical Care; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D007223:Infant; D007262:Infusions, Intravenous; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013577:Syndrome
chemical_list: D015415:Biomarkers; D005227:Fatty Acids; D006993:Hypnotics and Sedatives; D000108:Acetylcarnitine; D015742:Propofol